Radiographic Surveillance of Patients with Non-BRCA1/2 Pathogenic Variants

被引：0
|
作者：
Laura Hudson
Nicole Gower
Stacy Lenarcic
Sally J. Trufan
Richard L. White
机构：
[1] Levine Cancer Institute,Division of Surgical Oncology, Department of Surgery, Carolinas Medical Center
[2] Levine Cancer Institute,Department of Cancer Biostatistics
[3] Levine Cancer Institute,Department of Genetics
来源：
Annals of Surgical Oncology | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2248 / 2254
页数：6
相关论文
共 50 条
  • [41] microRNA based classification of non-BRCA1/2 hereditary breast cancer tumors
    Tanic, Miljana
    Marquez-Rodas, Ivan
    Fernandez, Victoria
    Benitez, Javier
    Martinez-Delgado, Beatriz
    CANCER RESEARCH, 2012, 72
  • [42] Germline variants in non-BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival
    Kahn, Ryan M.
    Selenica, Pier
    Boerner, Thomas
    Xiao, Yonghong
    Sia, Tiffany
    Sheehan, Margaret
    Zhou, Qin
    Iasonos, Alexia
    Grisham, Rachel N.
    O'Cearbhaill, Roisin Eilish
    Long, Kara
    Chi, Dennis S.
    Stadler, Zsofia Kinga
    Offit, Kenneth
    Aghajanian, Carol
    Sabbatini, Paul
    Mandelker, Diana
    Zamarin, Dmitriy
    Weigelt, Britta
    Liu, Ying L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants
    Wen, Song
    Zhang, Meng
    Chen, Jiuan
    Hu, Li
    Sun, Jie
    Yao, Lu
    Xu, Ye
    Zhang, Juan
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (01) : 155 - 164
  • [44] Association Between Family History and Risk of Pancreatic Cancer in Patients With BRCA1 and BRCA2 Pathogenic Variants
    Shah, Ishani
    Silva-Santisteban, Andy
    Germansky, Katharine A.
    Kandasamy, Cinthana
    Mlabasati, Jack
    Huang, Dora C. C.
    Wadhwa, Vaibhav
    Bilal, Mohammad
    Sawhney, Mandeep S.
    PANCREAS, 2022, 51 (07) : 733 - 738
  • [45] Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families
    Pouliot, Marie-Christine
    Kothari, Charu
    Joly-Beauparlant, Charles
    Labrie, Yvan
    Ouellette, Genevieve
    Simard, Jacques
    Droit, Arnaud
    Durocher, Francine
    ONCOTARGET, 2017, 8 (45) : 78691 - 78712
  • [46] The Risk of Contralateral Breast Cancer in BRCA1/2 Carriers Compared to Non-BRCA1/2 Carriers in an Unselected Cohort.
    van den Broek, A. J.
    Schmidt, M. K.
    Tollenaar, R. A. E. M.
    van't Veer, L. J.
    van Leeuwen, F. E.
    CANCER RESEARCH, 2011, 71
  • [47] Decision Coaching for Healthy Women With BRCA1/2 Pathogenic Variants
    Stock, Stephanie
    Isselhard, Anna
    Shukri, Arim
    Kautz-Freimuth, Sibylle
    Rhiem, Kerstin
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2024, 121 (12):
  • [48] Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants
    Vukovic, Petra
    Peccatori, Fedro Alessandro
    Massarotti, Claudia
    Miralles, Manuel Selvi
    Beketic-Oreskovic, Lidija
    Lambertini, Matteo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [49] Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants
    Robert Power
    Cristin Leavy
    Carmel Nolan
    Niamh White
    Roisin Clarke
    Karen A. Cadoo
    David James Gallagher
    Maeve Aine Lowery
    Familial Cancer, 2021, 20 : 97 - 101
  • [50] Dual BRCA1 and BRCA2 pathogenic variants in an adolescent with syndromic intellectual disability
    Algouneh, Arash
    Caudle, Michelle
    Balci, Tugce
    Andrade, Andrea
    Penava, Debbie
    Saleh, Maha
    CLINICAL CASE REPORTS, 2022, 10 (08):
12345